6533b860fe1ef96bd12c30f6
RESEARCH PRODUCT
Value of serial magnetic resonance imaging in the assessment of brain metastases volume control during stereotactic radiosurgery
Andrea AnastasiF BencivinniFrancesco AgnelloMassimo GaliaAdele TaibbiGiovanna GiordanoTommaso Vincenzo BartolottaGianvincenzo SparaciaA. Bancosubject
medicine.medical_specialtyPseudo progressionBrain metastasemedicine.medical_treatmentPseudo-progressionVolume controlRadiosurgery03 medical and health sciencesMagnetic resonance imaging0302 clinical medicineRetrospective StudymedicineStereotactic radiosurgerymedicine.diagnostic_testbusiness.industryBrain metastasesMagnetic resonance imagingequipment and suppliesRadiation therapyRadiation therapySerial magnetic resonance imaging030220 oncology & carcinogenesisRadiologyNuclear medicinebusinesshuman activities030217 neurology & neurosurgerydescription
AIM To evaluate brain metastases volume control capabilities of stereotactic radiosurgery (SRS) through serial magnetic resonance (MR) imaging follow-up. METHODS MR examinations of 54 brain metastases in 31 patients before and after SRS were reviewed. Patients were included in this study if they had a pre-treatment MR examination and serial follow-up MR examinations at 6 wk, 9 wk, 12 wk, and 12 mo after SRS. The metastasis volume change was categorized at each follow-up as increased (> 20% of the initial volume), stable (± 20% of the initial volume) or decreased (< 20% of the initial volume). RESULTS A local tumor control with a significant (P < 0.05) volume decrease was observed in 25 metastases at 6-wk follow-up. Not significant volume change was observed in 23 metastases and a significant volume increase was observed in 6 metastases. At 9-wk follow-up, 15 out of 25 metastases that decreased in size at 6 wk had a transient tumor volume increase, followed by tumor regression at 12 wk. At 12-wk follow-up there was a significant reduction in volume in 45 metastases, and a significant volume increase in 4 metastases. At 12-mo follow-up, 19 metastases increased significantly in size (up to 41% of the initial volume). Volume tumor reduction was correlated to histopathologic subtype. CONCLUSION SRS provided an effective local brain metastases volume control that was demonstrated at follow-up MR imaging.
year | journal | country | edition | language |
---|---|---|---|---|
2016-12-01 | World Journal of Radiology |